Egyptian Drug Authority · Egypt
DEA-EG-2022-0033
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(33) For 2022
- Date issued
- 24 Nov 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Napizole 20mg 14 caps
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 120118
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
تحذر هيئة الدواء المصرية من العبوات المقلدة من المستحضر التالي
حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة
للمستحضر المذكور -وذلك بناءً على ما ورد إلينا من الشركة صاحبة
المستحضر- كالآتي:
منشور
غش تجاري
Napizole 20mg 14 caps
120118تشغيلة رقم
مدون على العبوة تصنيع : جلوبال نابى للأدوية
٤٢ نوفمبر٢٢٠٢
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Napizole 20mg 14 caps
120118تشغيلة رقم
مدون على العبوة تصنيع : جلوبال نابى للأدوية
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Napizole 20mg 14 caps
120118تشغيلة رقم
مدون على العبوة تصنيع : جلوبال نابى للأدويةOriginal language: ar
- Notice text in English
- Trade-counterfeiting circular, November 2022. The Egyptian Drug Authority warns against counterfeit packs of the following product: Napizole 20mg 14 caps, made by Global Napi Pharmaceuticals, batch number 120118 as printed on the pack. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 5731acf515066177bd87959ef8fcc289b0e358378c0526224377a70f41936d7fSHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:28 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0033: Napizole 20mg 14 caps — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0033Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.